AZN vs WAT · P/E 28, $288.38B cap vs P/E 32, rev $3.17B
AstraZeneca PLC (AZN) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the AZN and WAT stock pages for the full models.
Not investment advice.